EUVIMEDOpdag EUVIMED
Crossref

The role of p62 in cell death and survival of 5‐fluorouracil and oxaliplatin‐resistant colorectal cancer cells

Vilmante Zitkute iD, Andrius Jasinevicius iD, Guoda Vaitiekaite, Egle Kukcinaviciute iD, Bernadeta Aleksandraviciute iD, Eigile Eidenaite, Lukas Sudeikis iD, Violeta Jonusiene iD, Ausra Sasnauskiene iD

Journal of Cellular Biochemistry · 2023

DOI: 10.1002/jcb.30488 ↗

At a glance

Journal article in Journal of Cellular Biochemistry, 2023. Written by Vilmante Zitkute and 8 co-authors. Institution: Department of Biochemistry and Molecular Biology, Institute of Biosciences, Life Sciences Center, Vilnius University, Vilnius, Lithuania. Major MEDLINE topics: Fluorouracil, Colorectal Neoplasms. Cited 7 times so far (Crossref); 45 references. Funded by: Lietuvos Mokslo Taryba.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The protein sequestosome 1 (p62/SQSTM1) is primarily known as a selective autophagy cargo receptor, but due to its multidomain structure, it also has roles in the ubiquitin‐proteasome system, metabolism, cell death and survival signalling. The increase in p62 levels is detected in some types of cancers, including colorectal cancer (CRC). Chemoresistance is the main cause of high mortality rates of CRC patients. Since p62 can regulate both cell survival and death, it is a potential modulator of chemoresistance. The impact of p62 on molecular causes of chemoresistance in CRC cells is insufficiently analysed. Therefore, we aimed to determine the impact of p62 on apoptosis, RIPK1‐pRIPK3 axis, and IL‐8 levels in chemoresistant CRC cells. Our data revealed that p62 levels are higher in the 5‐fluorouracil (5‐FU)‐resistant HCT116/FU subline compared to the parental cell line. 5‐FU and oxaliplatin (OxaPt) treatment decreased p62 protein levels and it correlated with chemoresistance of HCT116 and DLD1 cell lines. The silencing of p62 increased CRC cell sensitivity to 5‐FU and OxaPt, hence p62 is one of the factors supporting chemoresistance. The downregulation of p62 reduced the activation of caspase‐3 and the levels of RIPK1 and pRIPK3. Furthermore, p62 silencing decreased the BAX/BCL2 ratio in the HCT116/FU subline and did not change the levels of apoptosis. Instead, p62 silencing reduced the amount of IL‐8 protein. Our results show that p62 impacts chemoresistance by stimulating prosurvival signalling.

Subjects

MeSH terms (MEDLINE)

FluorouracilColorectal NeoplasmsHumansOxaliplatinInterleukin-8Drug Resistance, NeoplasmCell DeathApoptosisCell Line, TumorGene Expression Regulation, Neoplastic

Author keywords

5-fluorouracilapoptosischemoresistancecolorectal cancercytokinesoxaliplatinp62/SQSTM1

Substances

OxaliplatinFluorouracilInterleukin-8

Authors and institutions

  • Department of Biochemistry and Molecular Biology, Institute of Biosciences, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

ORCID profiles: Vilmante Zitkute, Andrius Jasinevicius, Egle Kukcinaviciute, Bernadeta Aleksandraviciute, Lukas Sudeikis, Violeta Jonusiene, Ausra Sasnauskiene

Funding

  • Lietuvos Mokslo Taryba

Cite

APA

Zitkute, V., Jasinevicius, A., Vaitiekaite, G., Kukcinaviciute, E., Aleksandraviciute, B., Eidenaite, E., Sudeikis, L., Jonusiene, V., & Sasnauskiene, A. (2023). The role of p62 in cell death and survival of 5‐fluorouracil and oxaliplatin‐resistant colorectal cancer cells. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30488

Vancouver

Zitkute V, Jasinevicius A, Vaitiekaite G, Kukcinaviciute E, Aleksandraviciute B, Eidenaite E, et al. The role of p62 in cell death and survival of 5‐fluorouracil and oxaliplatin‐resistant colorectal cancer cells. Journal of Cellular Biochemistry. 2023. doi:10.1002/jcb.30488

BibTeX
@article{Zitkute2023,
  author = {Zitkute, Vilmante and Jasinevicius, Andrius and Vaitiekaite, Guoda and Kukcinaviciute, Egle and Aleksandraviciute, Bernadeta and Eidenaite, Eigile and Sudeikis, Lukas and Jonusiene, Violeta and Sasnauskiene, Ausra},
  title = {The role of p62 in cell death and survival of 5‐fluorouracil and oxaliplatin‐resistant colorectal cancer cells},
  journal = {Journal of Cellular Biochemistry},
  year = {2023},
  doi = {10.1002/jcb.30488}
}
Start for free →